Patents by Inventor Nathan Davies
Nathan Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11947000Abstract: Systems, methods, and computer-readable media are described for compact radar systems. In some examples, a compact radar system can include a first set of transmit antennas, a second set of receive antennas, one or more processors, and at least one computer-readable storage medium storing computer-executable instructions which, when executed by the one or more processors, cause the radar system to coordinate digital beam steering of the first set of transmit antennas and the second set of receive antennas, and coordinate digital beam forming with one or more of the second set of receive antennas to detect one or more objects within a distance of the radar system.Type: GrantFiled: June 6, 2022Date of Patent: April 2, 2024Assignee: FORTEM TECHNOLOGIES, INC.Inventors: Adam Eugene Robertson, Jon Erik Knabenschuh, Lyman Davies Horne, Tyler Drue Park, Matthew Robertson Morin, James David Mackie, Matthew Elliott Argyle, Bryan Alan Davis, Chester Parker Ferry, Daniel Glen Bezzant, Justin Craig Huntington, Nathan James Packard
-
Patent number: 11547783Abstract: A blood filter device having an iron-chelating molecule, a haem-binding molecule and a haemoglobin-binding molecule bound to a support. Use of the device in a vessel containing blood, for example a blood bag or a flow line, removes haemolysis-derived components from the blood.Type: GrantFiled: December 2, 2015Date of Patent: January 10, 2023Assignees: IMPERIAL COLLEGE INNOVATIONS LIMITED, UCL BUSINESS LTDInventors: Alan Christopher Spivey, Gregory John Quinlan, Nathan Davies
-
Publication number: 20180015211Abstract: A blood filter device having an iron-chelating molecule, a haem-binding molecule and a haemoglobin-binding molecule bound to a support. Use of the device in a vessel containing blood, for example a blood bag or a flow line, removes haemolysis-derived components from the blood.Type: ApplicationFiled: December 2, 2015Publication date: January 18, 2018Applicants: IMPERIAL INNOVATIONS LIMITED, UCL BUSINESS PLCInventors: Alan Christopher Spivey, Gregory John Quinlan, Nathan Davies
-
Patent number: 9657884Abstract: A pipe crawler for crawling inside a pipe having an inside wall includes a front leg assembly that has front legs and feet. It also includes a rear leg assembly that has rear legs and feet. The rear leg assembly is disposed at a distance from the front leg assembly. A midsection operably couples the front leg assembly to the rear leg assembly and is configured to extend and contract the distance between the front leg assembly and the rear leg assembly. A plurality of lever arms are pivotably coupled between the front legs and their corresponding assemblies. The lever arms, in response to a force applied in an orientation traveling from the front of the pipe crawler to the rear of the pipe crawler, are configured to redirect a portion of the force into a normal force between the feet and the pipe inside wall.Type: GrantFiled: April 27, 2015Date of Patent: May 23, 2017Assignee: The United States of America as represented by the Secretary of the Air ForceInventors: David B. Carte, Marko Podplatnik, Nathan Tangeman, Nathan Davies, Ryan Boedeker, Kyle Fitle, Christopher Caldrone, Kelsey Brush
-
Patent number: 8480607Abstract: The invention provides an apparatus for use in the treatment of an individual suffering from liver disease, including: (a) means for selectively removing albumin from the blood of the individual; and (b) means for selectively removing endotoxin from the blood of the individual.Type: GrantFiled: October 29, 2007Date of Patent: July 9, 2013Assignee: UCL Business PLCInventors: Nathan Davies, Rajiv Jalan
-
Patent number: 8455220Abstract: A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA): albumin ratio (IMAR) in the individual, thereby to assess liver function in the individual.Type: GrantFiled: September 7, 2007Date of Patent: June 4, 2013Assignee: UCL Business PLCInventors: Rajiv Jalan, Rajeshwar P Mookerjee, Nathan Davies
-
Patent number: 8415117Abstract: A method for assessing prognosis in an individual suffering from liver failure, which method comprises detecting endotoxin in the individual, for example by determining the neutrophil function in the individual. The method can be used to determine whether there is an increased risk of infection in the individual, an increased risk of organ failure in the individual, an increased risk of mortality in the individual and/or an increased risk that the individual will not respond positively to treatment with an immunosuppressive agent, a steroid or an antibiotic.Type: GrantFiled: October 29, 2007Date of Patent: April 9, 2013Assignee: UCL Business PLCInventors: Rajiv Jalan, Rajeshwar P Mookerjee, Vanessa Stadlbauer, Nathan Davies
-
Publication number: 20100297018Abstract: A method for assessing prognosis in an individual suffering from liver failure, which method comprises detecting endotoxin in the individual, for example by determining the neutrophil function in the individual. The method can be used to determine whether there is an increased risk of infection in the individual, an increased risk of organ failure in the individual, an increased risk of mortality in the individual and/or an increased risk that the individual will not respond positively to treatment with an immunosuppressive agent, a steroid or an antibiotic.Type: ApplicationFiled: October 29, 2007Publication date: November 25, 2010Applicant: UCL Business PLCInventors: Rajiv Jalan, Rajeshwar P. Mookerjee, Vanessa Stadlbauer, Nathan Davies
-
Publication number: 20100025328Abstract: The invention provides an apparatus for use in the treatment of an individual suffering from liver disease, including: (a) means for selectively removing albumin from the blood of the individual; and (b) means for selectively removing endotoxin from the blood of the individual.Type: ApplicationFiled: October 29, 2007Publication date: February 4, 2010Inventors: Nathan Davies, Rajiv Jalan
-
Publication number: 20090280519Abstract: A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA):albumin ratio (IMAR) in the individual, thereby to assess liver function in the individual.Type: ApplicationFiled: September 7, 2007Publication date: November 12, 2009Inventors: Rajiv Jalan, Rajeshwar P. Mookerjee, Nathan Davies